Clinical Trial Update: Depot Contraception With and Without Lopinavir/Ritonavir [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating depot contraception with and without lopinavir/ritonavir for individuals with HIV infection was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Depo-Provera (medroxyprogesterone acetate)
• Kaletra (lopinavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV Infection | Phase 1 | Status: WITHDRAWN